Related Experiment Videos
[Macrophage activation syndrome]
Olivier Fain1, Jérôme Stirnemann
1Service de médecine interne, Hôpital Jean Verdier (AP-HP), Université Paris 13, 93140 Bondy. olivier.fain@jvr.ap-hop-paris.fr
La Revue Du Praticien
|August 7, 2004
Summary
Macrophage activation syndrome (MAS) is a severe immune response triggered by infections or cancers, leading to excessive cytokine release. Prompt diagnosis and treatment targeting the cause, alongside immunosuppressants, are crucial for survival.
Area of Science:
- Hematology
- Immunology
- Oncology
Context:
- Macrophage activation syndrome (MAS) is a critical condition characterized by excessive cytokine secretion and macrophage overstimulation.
- It is frequently triggered by infections, particularly viral, and neoplastic diseases such as lymphomas, often occurring in immunocompromised individuals.
Purpose:
- To elucidate the pathophysiology, clinical manifestations, diagnostic criteria, and therapeutic strategies for Macrophage Activation Syndrome.
- To highlight the urgent need for timely diagnosis and management of this life-threatening condition.
Summary:
- MAS results from macrophage hyperactivation, leading to symptoms including fever, enlarged liver and spleen, lymphadenopathy, cytopenias, and elevated lactate dehydrogenase, triglycerides, and ferritin.
- Diagnosis relies on identifying macrophage phagocytosis in bone marrow or liver biopsies.
- Treatment involves addressing the underlying cause, often with corticosteroids, chemotherapy (e.g., etoposide), or intravenous immunoglobulins.
Impact:
- Understanding MAS is vital for improving patient outcomes in critical care and hematology-oncology settings.
- Effective management strategies can mitigate the potentially fatal consequences of this hyperinflammatory syndrome.